Importantly, this work provides the foundation for the development of novel therapeutic strategies targeting PepT1-mediated intestinal protein-sensing mechanisms to reduce blood glucose levels in metabolic disease. The gene discussed is SLC15A1; the disease is Other metabolic disease.